JNJ vs ELV
By Alex · Tickerpine
Johnson & Johnson vs Elevance Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | ELV |
|---|---|---|
| Price | $260.86 | $399.14 |
| Market cap | $628.65B | $86.56B |
| P/E ratio | 30.3 | 17.3 |
| ROE | 25.74% | 11.13% |
| Profit margin | 21.48% | 2.47% |
| Revenue growth | 6.60% | 1.40% |
| Dividend yield | 2.05% | 1.76% |
| Beta | 0.23 | 0.69 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs ELV in plain English
- JNJ is the bigger company — about 7.3× the market cap of ELV.
- ELV is cheaper on earnings (P/E 17.3 vs 30.3).
- JNJ earns a higher return on equity (26% vs 11%).
- JNJ is growing revenue faster (7% vs 1%).
- JNJ has the higher dividend yield (2.05% vs 1.76%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
ELV return calculator
See what $1,000 in Elevance Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.